Credit Suisse’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $32.1M | Sell |
1,566,246
-9,975
| -0.6% | -$205K | 0.03% | 499 |
|
|
2023
Q4 | $33.8M | Buy |
1,576,221
+8,912
| +0.6% | +$191K | 0.03% | 497 |
|
|
2023
Q3 | $32.3M | Sell |
1,567,309
-5,739
| -0.4% | -$118K | 0.03% | 496 |
|
|
2023
Q2 | $46.4M | Buy |
1,573,048
+19,576
| +1% | +$578K | 0.05% | 419 |
|
|
2023
Q1 | $35.8M | Buy |
1,553,472
+20,089
| +1% | +$463K | 0.04% | 489 |
|
|
2022
Q4 | $42.6M | Sell |
1,533,383
-78,046
| -5% | -$2.17M | 0.05% | 433 |
|
|
2022
Q3 | $49.5M | Sell |
1,611,429
-348,596
| -18% | -$10.7M | 0.06% | 366 |
|
|
2022
Q2 | $57.7M | Buy |
1,960,025
+1,451
| +0.1% | +$42.7K | 0.06% | 333 |
|
|
2022
Q1 | $63M | Sell |
1,958,574
-5,074
| -0.3% | -$163K | 0.05% | 362 |
|
|
2021
Q4 | $87.6M | Sell |
1,963,648
-18,825
| -0.9% | -$840K | 0.05% | 290 |
|
|
2021
Q3 | $100M | Buy |
1,982,473
+15,965
| +0.8% | +$805K | 0.06% | 261 |
|
|
2021
Q2 | $154M | Buy |
1,966,508
+8,515
| +0.4% | +$668K | 0.08% | 191 |
|
|
2021
Q1 | $112M | Buy |
1,957,993
+555,243
| +40% | +$31.7M | 0.06% | 275 |
|
|
2020
Q4 | $117M | Buy |
1,402,750
+1,321,486
| +1,626% | +$111M | 0.06% | 243 |
|
|
2020
Q3 | $2.91M | Sell |
81,264
-21,383
| -21% | -$766K | ﹤0.01% | 1590 |
|
|
2020
Q2 | $2.48M | Buy |
102,647
+61,340
| +148% | +$1.48M | ﹤0.01% | 1710 |
|
|
2020
Q1 | $723K | Sell |
41,307
-697
| -2% | -$12.2K | ﹤0.01% | 2332 |
|
|
2019
Q4 | $732K | Sell |
42,004
-5,894
| -12% | -$103K | ﹤0.01% | 2707 |
|
|
2019
Q3 | $734K | Buy |
47,898
+6,711
| +16% | +$103K | ﹤0.01% | 2590 |
|
|
2019
Q2 | $854K | Sell |
41,187
-4,577
| -10% | -$94.9K | ﹤0.01% | 2463 |
|
|
2019
Q1 | $1.06M | Buy |
45,764
+1,673
| +4% | +$38.9K | ﹤0.01% | 2319 |
|
|
2018
Q4 | $910K | Buy |
44,091
+18,197
| +70% | +$376K | ﹤0.01% | 2364 |
|
|
2018
Q3 | $564K | Buy |
25,894
+13,960
| +117% | +$304K | ﹤0.01% | 2769 |
|
|
2018
Q2 | $181K | Buy |
+11,934
| New | +$181K | ﹤0.01% | 3318 |
|